- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00883805
Investigation of Systemic Metal Ion Concentration Following a Ceramic-on-metal Total Hip Arthroplasty
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a pilot study to compare systemic concentrations of cobalt and chromium in patients that have previously undergone total hip arthroplasties with ceramic on metal and metal on metal bearing surfaces. Secondary goals include an assessment of osteolysis on radiographs, potential long term analysis of implant survivability, and cancer rates in the two patient populations.
Increased metal ion production has been documented in metal-on-metal arthroplasty articulations. There are several concerns over metal ion production. First, even though there is a decreased histiocytic response to metallic debris, a dose dependent cytotoxic response with Interleukin 6, Prostaglandin E2, and Tumor Necrosis Factor alpha persists and may cause osteolysis in the long term. Second, increased levels of cobalt, chromium and nickel has been shown to correlate with increased cancer rates in several animal models, and the carcinogenic risk in humans has not been fully elucidated as yet. Third, hypersensitivity reactions to metal ion develop in up to 25% of these patients, and 60% of patients with poorly functioning hip.
Ceramic on metal avoids many of these problems due to the improved wear characteristics. If the level of metal ion production is significantly reduced and the implant survivability is proven in long term studies, this articulation may become the preferred method.
Study Type
Contacts and Locations
Study Locations
-
-
New York
-
Manhasset, New York, United States, 11030
- Feinstein Institute for Medical Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject is 40 - 80, who has undergone a top hip arthroplasty with either metal on metal or ceramic on metal articulation for a diagnosis of non-inflammatory degenerative joint disease. We will also include subjects who have had bilateral hip arthroplasties or a second arthroplasty performed since the initial surgery.
- Patient must be able to provide consent to participate
Exclusion Criteria:
- Diagnosis other than non-inflammatory degenerative joint disease, chronic renal insufficiency, or any systemic inflammatory condition
- Evidence of active infections
- Patients whose occupations include welding or metal working
- A second arthroplasty performed since the initial will not be exclude, but their data will be analyzed as a subpopulation
- unwillingness to comply with rehabilitation program or inability to return for follow-up visits
- Any systemic steroid therapy within 3 months of surgery
- Subjects who are pregnant
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Metal-on-Metal Articulations
Subjects will be people who have had metal-on-metal total hip arthroplasties
|
Subjects will give blood for analysis of metal ion concentrations
Subject will have x-ray of hip to assessment of osteolysis
|
Ceramic-on-Metal Articulations
Subjects will be people who have had ceramic-on-metal total hip arthroplasties
|
Subjects will give blood for analysis of metal ion concentrations
Subject will have x-ray of hip to assessment of osteolysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
metal ion concentration in urine
Time Frame: 1 year post-op
|
1 year post-op
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
metal ion concentration in blood
Time Frame: 1 year post-op
|
1 year post-op
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel Grande, Ph.D., Feinstein Institute for Medical Research
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- GCRC 0163
- IRB# 07-08-105
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthopaedic Surgery
-
Aalborg University HospitalAalborg UniversityCompleted
-
Jan Odom ForrenCompletedOrthopaedic SurgeryUnited States
-
Mahidol UniversityUnknownOrthopaedic SurgeryThailand
-
Royal United Hospitals Bath NHS Foundation TrustUniversity of Bath; Great Western Hospitals NHS Foundation TrustRecruitingOrthopaedic SurgeryUnited Kingdom
-
University Hospital, MontpellierCompleted
-
Centre Hospitalier Universitaire DijonCompletedHospitalization in Cardiology, Orthopaedic Surgery or Endocrinology DepartmentsFrance
-
Centre Hospitalier Universitaire de Saint EtienneBayerTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedOrthopaedic SurgeryFrance
-
University Hospital, MontpellierCompletedOrthopaedic Surgery | TraumatologyFrance
-
Massachusetts General HospitalCompletedMindfulness | Orthopaedic InjuryUnited States
Clinical Trials on Blood draw
-
Abbott Point of CareNot yet recruitingPrecision of Potassium (K) Test in Capillary Whole Blood
-
University Hospital, Strasbourg, FranceNot yet recruitingKidney Transplantation | Humoral Rejection | Kidney Allograft Biopsy | Microvascular Inflammation
-
Vanderbilt-Ingram Cancer CenterWren Laboratories LLCCompletedMelanomaUnited States
-
Turtle Health, Inc.Completed
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
National Heart Centre SingaporeDuke-NUS Graduate Medical SchoolRecruiting
-
Duke UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingHematologic MalignancyUnited States
-
University of BonnRecruitingSARS-CoV 2 | COVIDGermany
-
Joseph M. Still Research Foundation, Inc.RecruitingInflammatory Response | Deep Vein Thrombosis | Multi Organ Failure | Nosocomial InfectionUnited States